Post-Marketing Drug Surveillance
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
How much did regular use of Vioxx for long periods of time increase the risk of heart attack? What is the risk of suicide with the SSRI’s in select patient populations? The answers can only come through a robust system for monitoring post-marketing drug safety. Yet the new regulations being considered by the FDA and Congress may not be a prescription for improved safety.
Recommended
Details
Presenters
Overview
How much did regular use of Vioxx for long periods of time increase the risk of heart attack? What is the risk of suicide with the SSRI’s in select patient populations? The answers can only come through a robust system for monitoring post-marketing drug safety. Yet the new regulations being considered by the FDA and Congress may not be a prescription for improved safety.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?